Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne R Hayman

Showing results (81-90 of 242) with videos related to

Pageof 25
Sort By:
American Journal of Hematology|August 12, 2014
Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasiasTaxiarchis V Kourelis, Shaji K Kumar, Ronald S Go, et al.
American Journal of Hematology|November 13, 2014
Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosisGregory P Kaufman, Angela Dispenzieri, Morie A Gertz, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2023
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple MyelomaSarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, et al.
Blood|November 9, 2011
Immunoglobulin D amyloidosis: a distinct entityMorie A Gertz, Francis K Buadi, Suzanne R Hayman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2013
Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantationAbhishek Singla, William J Hogan, Stephen M Ansell, et al.
Blood|June 25, 2014
Trends in survival of patients with primary plasma cell leukemia: a population-based analysisWilson I Gonsalves, S Vincent Rajkumar, Ronald S Go, et al.
American Journal of Hematology|May 3, 2012
Trends and outcomes of modern staging of solitary plasmacytoma of boneRahma Warsame, Morie A Gertz, Martha Q Lacy, et al.
Haematologica|August 2, 2016
Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen typeEli Muchtar, Angela Dispenzieri, Shaji K Kumar, et al.
Mayo Clinic Proceedings|July 5, 2022
Incidence and Risk Factors for Acute Kidney Injury After Chimeric Antigen Receptor T-Cell TherapyNaba Farooqui, Janina Paula T Sy-Go, Jing Miao, et al.
Blood Cancer Journal|April 12, 2022
Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantationAbdullah S Al Saleh, Mohammad S Ebraheem, M Hasib Sidiqi, et al.
Pageof 25

Showing results (81-90 of 242) with videos related to

Sort By:
Pageof 25
American Journal of Hematology|August 12, 2014
Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasiasTaxiarchis V Kourelis, Shaji K Kumar, Ronald S Go, et al.
American Journal of Hematology|November 13, 2014
Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosisGregory P Kaufman, Angela Dispenzieri, Morie A Gertz, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2023
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple MyelomaSarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, et al.
Blood|November 9, 2011
Immunoglobulin D amyloidosis: a distinct entityMorie A Gertz, Francis K Buadi, Suzanne R Hayman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2013
Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantationAbhishek Singla, William J Hogan, Stephen M Ansell, et al.
Blood|June 25, 2014
Trends in survival of patients with primary plasma cell leukemia: a population-based analysisWilson I Gonsalves, S Vincent Rajkumar, Ronald S Go, et al.
American Journal of Hematology|May 3, 2012
Trends and outcomes of modern staging of solitary plasmacytoma of boneRahma Warsame, Morie A Gertz, Martha Q Lacy, et al.
Haematologica|August 2, 2016
Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen typeEli Muchtar, Angela Dispenzieri, Shaji K Kumar, et al.
Mayo Clinic Proceedings|July 5, 2022
Incidence and Risk Factors for Acute Kidney Injury After Chimeric Antigen Receptor T-Cell TherapyNaba Farooqui, Janina Paula T Sy-Go, Jing Miao, et al.
Blood Cancer Journal|April 12, 2022
Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantationAbdullah S Al Saleh, Mohammad S Ebraheem, M Hasib Sidiqi, et al.
Pageof 25